Tau kinase inhibition for treatment of Alzheimer's disease

被引：0
|
作者：
Bhat, R [1 ]
机构：
[1] AstraZeneca, Preclin DMPK, Sodertalje, Sweden
来源：
EUROPEAN NEUROPSYCHOPHARMACOLOGY | 2003年 / 13卷
关键词：
D O I：
10.1016/S0924-977X(03)91635-X
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：S119 / S119
页数：1
相关论文
共 50 条
  • [31] Tau kinetics in Alzheimer's disease
    Hier, Daniel B.
    Azizi, Sima
    Thimgan, Matthew S.
    Wunsch II, Donald C. C.
    FRONTIERS IN AGING NEUROSCIENCE, 2022, 14
  • [32] Tau immunotherapy for Alzheimer's disease
    Pedersen, Jan Torleif
    Sigurdsson, Einar M.
    TRENDS IN MOLECULAR MEDICINE, 2015, 21 (06) : 394 - 402
  • [33] Reduction of phosphorylated tau during memantine treatment of Alzheimer's disease
    Gunnarsson, M. Degerman
    Kilander, L.
    Basun, H.
    Lannfelt, L.
    DEMENTIA AND GERIATRIC COGNITIVE DISORDERS, 2007, 24 (04) : 247 - 252
  • [34] Silymarin's Inhibition and Treatment Effects for Alzheimer's Disease
    Guo, Hong
    Cao, Hui
    Cui, Xiaowei
    Zheng, Wenxiu
    Wang, Shanshan
    Yu, Jiyang
    Chen, Zhi
    MOLECULES, 2019, 24 (09):
  • [35] Calpain Inhibition as a Potential Treatment of Alzheimer's Disease
    Getz, Godfrey S.
    AMERICAN JOURNAL OF PATHOLOGY, 2012, 181 (02): : 388 - 391
  • [36] Glycogen Synthase Kinase-3β and Tau Genes Interact in Alzheimer's Disease
    Kwok, John B. J.
    Loy, Clement T.
    Hamilton, Gillian
    Lau, Edmond
    Hallupp, Marianne
    Williams, Julie
    Owen, Michael J.
    Broe, G. Anthony
    Tang, Nelson
    Lam, Linda
    Powell, John F.
    Lovestone, Simon
    Schofield, Peter R.
    ANNALS OF NEUROLOGY, 2008, 64 (04) : 446 - 454
  • [37] Engineering a pathological tau-targeted nanochaperone for selective and synergetic inhibition of tau pathology in Alzheimer's Disease
    Xu, Linlin
    Ding, Yuxun
    Ma, Feihe
    Chen, Yue
    Chen, Guidong
    Zhu, Lin
    Long, Jiafu
    Ma, Rujiang
    Liu, Yang
    Liu, Jianfeng
    Huang, Fan
    Shi, Linqi
    NANO TODAY, 2022, 43
  • [38] Beyond Secretases: Kinase Inhibitors for the Treatment of Alzheimer's Disease
    Medda, Federico
    Smith, Breland
    Gokhale, Vijay
    Shaw, Arthur Y.
    Dunckley, Travis
    Hulme, Christopher
    ANNUAL REPORTS IN MEDICINAL CHEMISTRY, VOL 48, 2013, 48 : 57 - 71
  • [39] Role of PIM Kinase Inhibitor in the Treatment of Alzheimer's Disease
    Meur, Shreyasi
    Mukherjee, Swarupananda
    Roy, Souvik
    Karati, Dipanjan
    MOLECULAR NEUROBIOLOGY, 2024, : 10941 - 10955
  • [40] Tau protein's role in Alzheimer's disease
    不详
    CHEMICAL & ENGINEERING NEWS, 2007, 85 (02) : 44 - 44
12345